|
|||
|
|
LX Sleep Let LX® Sleep be the answer to your dreams with in-home, overnight, unattended, multi-parameter, sleep study for detection of OSA (Obstructive Sleep Apnea). This convenient HST (Home Sleep Test) device provides a conforming methodology for multi-parameter, overnight, unattended sleep study that is described in CMA’s NCD (National Coverage Decision) CAG-00093R2. LX® Sleep software applies proprietary algorithms to data collected by NorthEast’s OxyHolter to provide a simple alternative to the PSG sleep lab experience to accurately identify OSA (Obstructive Sleep Apnea). LX® Sleep defines epochs of normal versus SDB (Sleep Disordered Breathing). Then it performs pattern recognition on ECG and SpO2 signals; and applies a linear discriminant analysis and an age-based classifier to derive an AHI (Apnea Hypopnea Index). An AHI < 5 represents no clinically significant apnea; 5 < AHI < 15 represents mild apnea; AHI >15 represents moderate-to-severe apnea.* Current users of Holter LX® Analysis and/or the tried-and-true DR180+ can easily add the LX® Sleep software option and an OxyHolter cable, thereby creating the most accurate, easy-to-use OSA detection system on the market today. For more information on LX® Sleep, please contact NorthEast or click here to view LX Sleep datasheet pdf. *As per Decision Memo for Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) (CAG-00093R2); March 13, 2008. |
||
|
copyright ©2010 NorthEast Monitoring, Inc. Phone:(978)461-3992 Toll-Free:866-346-5837 info@nemon.com |
|||
